The Activity of Antiparkinsonian Drug Hemantane in Models of Peripheral Inflammation and Lipopolysaccharide-Induced Neuroinflammation
Advances in Parkinson's Disease
doi 10.4236/apd.2013.21003
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Scientific Research Publishing, Inc.